USPTO serial 99452342
AHBA
Reviewed by CopyMark Law Group
Status 681
- Filing date
- Status date
- Registration date
- —
- Examiner
- KOSICH, TRISTAN NMN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with AHBA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Newport Beach, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
SABA NEIL DANESHVAR
SABA NEIL DANESHVAR Saba Daneshvar Law, LLC1179 Gilbert Street SEAtlanta, GA 30316United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Vitamins; Vitamin supplements; Vitamin tablets; Prenatal vitamins; Synthetic peptides for the treatment of inflammation and pain; Synthetic peptides for the treatment of chronic pain; Synthetic peptides for the treatment of neurodegenerative diseases; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for the treatment and prevention of inflammation and pain; Pharmaceutical preparations for the treatment and prevention of chronic pain; Pharmaceutical products for the treatment of viral diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical products for the treatment of cancer; Pharmaceuticals, namely, psychotropics; Psychotropics; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical skin lotions; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicinal tea; Herbal teas for medicinal purposes; Synthetic peptides for the treatment of cancer | ACTIVE | — |
| 025 | Clothing, namely, athletic shirts, shorts, and pants; Clothing, namely, clothing for medical professionals in the nature of scrub tops and pants not for surgical purposes; Clothing, namely, medical scrubs in the nature of scrub tops and pants not for surgical purposes; Clothing, namely, lab coats; Clothing, namely, medical tunics in the nature of scrub tops not for surgical purposes; Clothing, namely, socks; Socks; Men's socks; Men's dress socks; Sport socks; Shirts; Athletic shirts; T-shirts; T-shirts for babies, children, men and women; Shirts for infants, babies, toddlers and children; Shirts for babies, children, men and women.; Athletic shorts; Shorts; Shorts for babies, children, men and women.; Infants' shoes; Shoes; Shoe straps; Sports shoes; Shoes for babies, children, men and women.; Shoes for infants; Sandals and beach shoes; Bath sandals; Sun protective clothing, namely, shirts, hats, shorts and pants | ACTIVE | — |
| 028 | Exercise equipment, namely, exercise bands; Exercise equipment in the nature of exercise bands; Exercise equipment, namely, weighted bars; Exercise equipment in the nature of weighted bars; Dumbbells; Dumbbell sets; Ankle weights; Exercise weights; Weighted vests for exercise; Yoga straps for use in meditation and yoga practice; Yoga blocks made of foam for use in yoga practice; Yoga blocks made of cork for use in yoga practice | ACTIVE | — |
| 029 | Nut milk; Nut milk-based beverages; Nut butters; Seed butters; Egg whites; Processed eggs; Egg yolks; Hen eggs; Duck eggs; Prepared and prepackaged meals and entrees consisting primarily of egg with one or more of meat, fish, poultry, vegetable, cheese or onion; Dried edible mushrooms | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 4, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 14, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 8, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 8, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 8, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 8, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 8, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 8, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 8, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 7, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 7, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 11, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 11, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 11, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 11, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 20, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 20, 2025 | NWAP | NEW APPLICATION ENTERED | — |